Mirae Asset Global Investments’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162K | Buy |
3,336
+519
| +18% | +$25.2K | ﹤0.01% | 1075 |
|
|
2025
Q1 | $104K | Sell |
2,817
-27
| -0.9% | -$999 | ﹤0.01% | 1122 |
|
|
2024
Q4 | $114K | Sell |
2,844
-236
| -8% | -$9.45K | ﹤0.01% | 1128 |
|
|
2024
Q3 | $146K | Buy |
3,080
+545
| +21% | +$25.8K | ﹤0.01% | 1139 |
|
|
2024
Q2 | $140K | Sell |
2,535
-164,011
| -98% | -$9.08M | ﹤0.01% | 1097 |
|
|
2024
Q1 | $7.45M | Buy |
166,546
+77,053
| +86% | +$3.45M | 0.02% | 760 |
|
|
2023
Q4 | $5.6M | Sell |
89,493
-95,361
| -52% | -$5.97M | 0.01% | 859 |
|
|
2023
Q3 | $8.39M | Buy |
184,854
+17,258
| +10% | +$783K | 0.02% | 683 |
|
|
2023
Q2 | $9.41M | Sell |
167,596
-3,571
| -2% | -$201K | 0.02% | 675 |
|
|
2023
Q1 | $7.74M | Buy |
171,167
+7,565
| +5% | +$342K | 0.02% | 736 |
|
|
2022
Q4 | $6.65M | Sell |
163,602
-5,173
| -3% | -$210K | 0.02% | 737 |
|
|
2022
Q3 | $11M | Buy |
168,775
+20,829
| +14% | +$1.36M | 0.03% | 548 |
|
|
2022
Q2 | $8.99M | Buy |
147,946
+42,564
| +40% | +$2.59M | 0.02% | 637 |
|
|
2022
Q1 | $6.62M | Sell |
105,382
-19,095
| -15% | -$1.2M | 0.01% | 787 |
|
|
2021
Q4 | $9.43M | Buy |
124,477
+35,829
| +40% | +$2.71M | 0.02% | 696 |
|
|
2021
Q3 | $9.92M | Buy |
88,648
+17,119
| +24% | +$1.92M | 0.03% | 650 |
|
|
2021
Q2 | $11.6M | Buy |
71,529
+47
| +0.1% | +$7.61K | 0.03% | 578 |
|
|
2021
Q1 | $8.71M | Buy |
71,482
+32,015
| +81% | +$3.9M | 0.03% | 574 |
|
|
2020
Q4 | $6.04M | Buy |
39,467
+381
| +1% | +$58.3K | 0.02% | 612 |
|
|
2020
Q3 | $3.27M | Buy |
39,086
+12,506
| +47% | +$1.05M | 0.02% | 642 |
|
|
2020
Q2 | $1.95M | Buy |
26,580
+14,309
| +117% | +$1.05M | 0.01% | 707 |
|
|
2020
Q1 | $520K | Buy |
12,271
+1,317
| +12% | +$55.8K | ﹤0.01% | 1013 |
|
|
2019
Q4 | $667K | Buy |
10,954
+1,690
| +18% | +$103K | ﹤0.01% | 1110 |
|
|
2019
Q3 | $380K | Buy |
+9,264
| New | +$380K | ﹤0.01% | 1246 |
|